HOME >> BIOLOGY >> NEWS
Antibody therapy can increase the effectiveness of cancer vaccine, early studys

ibody to patients who had already been vaccinated.

Seven of the study participants had metastatic melanoma, a potentially fatal cancer that originates in skin cells, and two had metastatic ovarian cancer. In all three melanoma patients who had been treated with one form of vaccine, tumors showed extensive signs of cell death and were saturated with large numbers of tumor-fighting immune cells. The same results were seen in the two ovarian cancer patients who had been treated with the same type of vaccine. (The vaccine is created by loading tumor cells with a gene called GM-CSF that alerts the immune system to the tumors' presence, prompting an anti-tumor attack.)

Of the four melanoma patients who had received a different type of vaccine based on melanoma antigens, none experienced a similar benefit, researchers found.

While none of the study participants had serious reactions to the antibody itself, some of the melanoma patients developed a mild immune reaction against normal skin cells called melanocytes, but it was not a dangerous side effect.

Previous clinical trials have shown that vaccines can be at least temporarily effective in treating metastatic melanoma and ovarian cancer, but most patients eventually succumb to their disease. One of the reasons for this may be that the CTLA-4 molecule gradually weakens the immune system's ability to recognize and respond to tumor cells.

"By blockading CTLA-4 with antibodies, we had hoped to strengthen the immune response produced by cancer vaccines," remarks Dranoff, who is also an associate professor of medicine at Harvard Medical School and a Leukemia and Lymphoma Society clinical scholar. "Work in the laboratory and in animal models suggested that this approach could be effective. The new study offers the first evidence that the technique has promise in human patients, although much more study will be needed to demonstrate that this is the case."

The study's lead a
'"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
1-Apr-2003


Page: 1 2 3

Related biology news :

1. Antibody coated stent a breakthrough in cardiovascular treatment
2. The spice of life: Antibody cocktail targets deadly foodborne germs
3. Dana-Farber launches NFCR Center for Therapeutic Antibody Research and Engineering
4. Antibody Revolution Targets STDs, Stomach Viruses, Common Cold
5. Novel Two-Antibody Strategy To Fight Cancer Awarded Patent
6. Targeted therapy knocks out pediatric brain cancer in mice
7. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
8. Columbia research to examine gene influence on severity of peridontal disease, therapy response
9. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
10. The search for a kinder, gentler chemotherapy
11. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/9/2018)... ... August 08, 2018 , ... Specialty Med ... helps physicians bring the latest regenerative therapies and treatment options to their patients, ... 2018 in White Plains, NY. , The 2-day clinical collaboration ...
(Date:8/7/2018)... ... 2018 , ... Nurse practitioners and physician ... healthcare careers in the past year, according to the second annual survey of ... with a wide variety of career- and employment-related resources including physician/candidate database, job ...
(Date:8/7/2018)... ... 07, 2018 , ... Nanomedical Diagnostics , leading manufacturer ... titled, “Synthetic Molecules for Disruption of the Myc Protein-Protein Interface ” in ... Agile R100, described as a “ field-effect transistor (Bio-FET) platform ,” to produce ...
Breaking Biology News(10 mins):
(Date:8/9/2018)... ... August 09, 2018 , ... Simpson Gumpertz ... (AEC) experts with building owners and managers for a full-day discussion on health ... symposium comes to Boston for the first time on Thursday, 13 September 2018, ...
(Date:8/1/2018)... ... August 01, 2018 , ... Roland ... of a proprietary biofield energy treated supplement that potentially improves the anti-inflammatory ... systemic and organ-specific inflammation, as well as, immune function response. The following ...
(Date:7/31/2018)... ... 31, 2018 , ... Mahoney Environmental , a leading ... new website. The new website has been designed with improved functionality and navigation, ... Innovative to build a website created for the customer. The newly redesigned site ...
(Date:7/25/2018)... ... July 25, 2018 , ... Eileen Meagher, ... of a biofield energy treated nutraceutical to improve skin health parameters including anti-wrinkling, ... skin health and reported the following results:,     More than ...
Breaking Biology Technology:
Cached News: